01 January 2001
Endothelial cell dysfunction in a model of oxidative stress.
Liming Jin, Gamal Abou-Mohamed, Ruth B Caldwell, William R CaldwellMed Sci Monit 2001; 7(4): BR585-591 :: ID: 421099
Abstract
BACKGROUND: We have investigated the role of L-arginine in hyperhomocysteinemia(HHCY). L-arginine is the substrate required for NO production by endothelial NOS (eNOS). When L-arginineis limited, NOS acts principally upon O2 to form superoxide (O2.-). Because HHCY causes formation ofreactive oxygen species and reduced endothelial-dependent vasodilation, we hypothesized that HHCY decreasesNO formation by limiting the cellular supply of L-arginine.MATERIAL AND METHODS: Studies with culturedbovine aortic endothelial cells (ECs) determined effects of HCY on transport of [3H] L-arginine. Effectson L-arginine transporter protein CAT-1 and eNOS protein were assessed by immunoblotting. Peroxynitriteformation was evaluated by an immunoassay for nitrotyrosine levels. eNOS activity in forming NO was determinedby assay for 3H-L-arginine to 3H-citrulline conversion.RESULTS: HCY had a depressive effect on argininetransport in ECs. HCY treatment for a 24 hr period decreased arginine uptake by 27%. HCY treatment for24 hr significantly reduced cellular levels of the CAT-1 arginine transporter protein ( approximately30%) and increased nitrotyrosine formation, whereas levels of eNOS protein and basal NOS activity werenot altered. Nevertheless, total NO production as indicated by citrulline conversion was significantlydecreased. Treatment with the antioxidant N-acetylcysteine reversed the HCY effect on arginine transport,suggesting that transporter oxidation may contribute to the endothelial dysfunction.CONCLUSIONS: Theassociation of HCY-induced decreases in NO formation with decreases in function and expression of thearginine transporter in the absence of alterations in eNOS expression or activity suggests a primaryrole for arginine transport alterations in HHCY. The action of HCY to reduce arginine uptake may accentuateendothelial dysfunction due to generation of O2.- and peroxynitrite formation, which may cause furtheroxidative injury.
Keywords: Hyperhomocysteinemia, L-arginine uptake, endothelial cell dysfunction,
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Database Analysis
Risk Factors of Age-Related Macular Degeneration in a Population-Based Study: Results from SHIP-TREND-1 (St...Med Sci Monit In Press; DOI: 10.12659/MSM.943140
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952